Since 2016, Ohio Medical, LLC (“Ohio Medical”), a global leader in oxygen regulators and central gas systems, partnered with a private equity firm to leverage analytics to create a performance-oriented culture, implement new systems to enhance transparency, and upgrade its manufacturing capabilities. Looking ahead to its future, Ohio Medical sought to accelerate its global expansion to better serve its customers under new ownership by ESAB Corporation (“ESAB”), a world leader in fabrication and gas control technology.
To support Ohio Medical’s goals in developing its capabilities worldwide with a new partner in ESAB, AGG Food & Drug of counsel Bob Durkin led AGG’s work in advising Ohio Medical on FDA-related due diligence matters during the transaction. AGG Food & Drug attorneys Alan Minsk and Kadeja Watts also assisted in the matter.
AGG’s counsel helped facilitate the successful closing of the $127 million sale of Ohio Medical to ESAB. The addition of Ohio Medical not only increases ESAB’s served market in North America, but also creates an unmatched global medical and industrial gas control portfolio that enhances its worldwide offerings.
To read the full press release, please click here.